CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 55 filers reported holding CTI BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $0 | – | 253 | +8.6% | 0.00% | – |
Q3 2016 | $0 | – | 233 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 233 | -99.7% | 0.00% | – |
Q1 2016 | $37,000 | -61.5% | 68,704 | -12.2% | 0.00% | – |
Q4 2015 | $96,000 | -16.5% | 78,268 | -0.2% | 0.00% | – |
Q3 2015 | $115,000 | -34.3% | 78,455 | -12.3% | 0.00% | – |
Q2 2015 | $175,000 | +28.7% | 89,479 | +18.1% | 0.00% | – |
Q1 2015 | $136,000 | +806.7% | 75,754 | +1117.3% | 0.00% | – |
Q4 2014 | $15,000 | 0.0% | 6,223 | +0.8% | 0.00% | – |
Q3 2014 | $15,000 | -44.4% | 6,171 | -35.3% | 0.00% | – |
Q2 2014 | $27,000 | – | 9,544 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |